← Back to headlines
Alnylam Pharmaceuticals Faces Target Trims Amid Growth Faith
Analysts have trimmed their targets for Alnylam Pharmaceuticals, Inc. (ALNY) but maintain faith in the company's growth prospects for 2026.
19 Feb, 05:01 — 19 Feb, 05:01
Sources
Showing 1 of 1 sources
